{"id":"https://openalex.org/A5115869753","orcid":null,"observed_orcids":[],"display_name":"Kenza BOUDEMAGH","raw_author_names":["Kenza BOUDEMAGH"],"full_name":"Kenza BOUDEMAGH","works_count":1,"cited_by_count":0,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":0,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5115869753","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I4391767747","ror":"https://ror.org/04wk25q62","display_name":"University of Constantine 3","country_code":"DZ","type":"education","lineage":["https://openalex.org/I4391767747"]},"years":[2024]}],"last_known_institutions":[{"id":"https://openalex.org/I4391767747","ror":"https://ror.org/04wk25q62","display_name":"University of Constantine 3","country_code":"DZ","type":"education","lineage":["https://openalex.org/I4391767747"]}],"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","count":1,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","count":1,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12845","display_name":"Methemoglobinemia and Tumor Lysis Syndrome","count":1,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12845","display_name":"Methemoglobinemia and Tumor Lysis Syndrome","value":3.49e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","value":1.48e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","value":5.6e-06,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","score":0.5503982901573181},{"id":"177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","score":0.45175305008888245},{"id":"2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","score":0.4382117986679077},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.21777811646461487},{"id":"2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","score":0.1584818959236145}],"counts_by_year":[{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":0}],"display_name_alternatives":["Kenza BOUDEMAGH"],"block_key":"k boudemagh","works_api_url":"https://api.openalex.org/works?filter=author.id:A5115869753","updated_date":"2026-10-05T12:30:24","created_date":"2025-01-14T00:00:00"}